- 全部删除
 
您的购物车当前为空
LDN-193189 Tetrahydrochloride(DM-3189 Tetrahydrochloride)是一种BMP I型受体的选择性抑制剂,可以抑制 ALK2 和 ALK3 (IC50=5/30 nM),对 ALK4、ALK5和ALK7的活性较弱,用于研究进行性骨化性纤维发育不良。

LDN-193189 Tetrahydrochloride(DM-3189 Tetrahydrochloride)是一种BMP I型受体的选择性抑制剂,可以抑制 ALK2 和 ALK3 (IC50=5/30 nM),对 ALK4、ALK5和ALK7的活性较弱,用于研究进行性骨化性纤维发育不良。
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 1 mg | ¥ 348  | In stock | |
| 5 mg | ¥ 813  | In stock | |
| 10 mg | ¥ 1,190  | In stock | |
| 25 mg | ¥ 1,960  | In stock | |
| 50 mg | ¥ 2,980  | In stock | |
| 100 mg | ¥ 4,380  | In stock | |
| 200 mg | ¥ 6,280  | In stock | 
LDN-193189 Tetrahydrochloride 相关产品
| 产品描述 | LDN-193189 Tetrahydrochloride (DM-3189 Tetrahydrochloride) is a selective inhibitor of BMP type I receptors, inhibiting ALK2 and ALK3 (IC₅₀ = 5/30 nM), with weaker activity against ALK4, ALK5, and ALK7, and can be used for research into progressive osseous fibrodysplasia.  | 
| 靶点活性 |  ACVR1:5 nM, BMPR1A:7 nM  | 
| 体外活性 | LDN-193189 Tetrahydrochloride 有效抑制 ALK4 和 ActRIIA 的激酶活性,IC50 值分别为 101 和 210 nM。[2]  | 
| 体内活性 | 方法:LDN-193189 Tetrahydrochloride(3mg/kg,腹腔注射,每天两次)处理MDA-PCa-118b肿瘤异种移植的SCID小鼠模型,每周测量一次肿瘤大小和体重,探究LDN-193189 Tetrahydrochloride对体内肿瘤生长的影响。  | 
| 别名 | LDN193189 Tetrahydrochloride, DM-3189 Tetrahydrochloride, DM3189 Tetrahydrochloride | 
| 分子量 | 552.33 | 
| 分子式 | C25H26Cl4N6 | 
| CAS No. | 2310134-98-4 | 
| Smiles | C1(C2=C3N=CC(C4=CC=C(N5CCNCC5)C=C4)=CN3N=C2)=C6C=CC=CC6=NC=C1.Cl.Cl.Cl.Cl | 
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | H2O: 25 mg/mL (45.26 mM), Sonication is recommended.  DMSO: 3.3 mg/mL (5.97 mM), Sonication is recommended.   | ||||||||||||||||||||||||||||||
溶液配制表  | |||||||||||||||||||||||||||||||
DMSO/H2O 
 H2O 
  | |||||||||||||||||||||||||||||||
评论内容